Search

everythinglearnresearchcommunity

for

Search:↓

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Combining doxazosin and finasteride is more effective for managing benign prostatic hyperplasia than using either drug alone.

A new hair loss treatment using dissolving microneedles was found to speed up hair growth and was more effective than daily use of common hair growth drugs.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Androstenedione, a hormone supplement, doesn't improve muscle or performance and can cause harmful side effects.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Letrozole may help prevent seizures by reducing certain hormone levels.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

The treatment changed hormone levels and increased sexual behavior in female capuchin monkeys.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

Saw palmetto extract can block the enzyme that converts testosterone in pig prostate cells.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Certain Dibenzo derivatives may help treat prostate cancer.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

AR-27 E-Chol siRNA can effectively regrow hair by reducing androgen receptor gene activity.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Certain hormones can reduce skin oil and hair growth, potentially helping treat acne and excessive hair in women.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Long-term finasteride use doesn't change bone density or metabolism.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.